References
-
1
de Franchis R.
Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension.
J Hepatol.
2000;
33
846-852
-
2
Moore K P, Wong F, Gines P. et al .
The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.
Hepatology.
2003;
38
258-266
-
3
Angermayr B, Cejna M, Peck-Radosavljevic M.
Management von Patienten vor und nach Implantation eines transjugulären intrahepatischen portosystemischen Shunts (TIPS) - Bericht der Vienna TIPS Study Group.
Journal für Gastroenterologische und Hepatologische Erkrankungen.
2003;
1
11-14
-
4
Bosch J, Garcia-Pagan J C.
Complications of cirrhosis. I. Portal hypertension.
J Hepatol.
2000;
32
141-156
-
5
D’Amico G, Pagliaro L, Bosch J.
Pharmacological treatment of portal hypertension: an evidence-based approach.
Semin Liver Dis.
1999;
19
475-505
-
6
Merkel C, Bolognesi M, Sacerdoti D. et al .
The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
Hepatology.
2000;
32
930-934
-
7
Abraldes J G, Tarantino I, Turnes J, Garcia-Pagan J C, Rodes J, Bosch J.
Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
Hepatology.
2003;
37
902-908
-
8
Garcia-Pagan J C, Morillas R, Banares R. et al .
Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT.
Hepatology.
2003;
37
1260-1266
-
9
Schepke M, Kleber G, Nurnberg D. et al .
Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis.
Hepatology.
2004;
40
65-72
-
10
Ben-Ari Z, Cardin F, McCormick A P, Wannamethee G, Burroughs A K.
A predictive model for failure to control bleeding during acute variceal haemorrhage.
J Hepatol.
1999;
31
443-450
-
11
Bernard B, Grange J D, Khac E N, Amiot X, Opolon P, Poynard T.
Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.
Hepatology.
1999;
29
1655-1661
-
12
Moitinho E, Escorsell A, Bandi J C. et al .
Prognostic value of early measurements of portal pressure in acute variceal bleeding.
Gastroenterology.
1999;
117
626-631
-
13
Bureau C, Peron J M, Alric L. et al .
”A La Carte” treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding.
Hepatology.
2002;
36
1361-1366
-
14
Cejna M, Peck-Radosavljevic M, Thurnher S. et al .
ePTFE-covered stent-grafts for revision of obstructed transjugular intrahepatic portosystemic shunt.
Cardiovasc Intervent Radiol.
2002;
25
365-372
-
15
Angermayr B, Cejna M, Koenig F. et al .
Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents.
Hepatology.
2003;
38
1043-1050
-
16
Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L. et al .
Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding.
Hepatology.
2004;
40
793-801
-
17
Primignani M, Carpinelli L, Preatoni P. et al .
Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC).
Gastroenterology.
2000;
119
181-187
-
18
Sarin S K, Lahoti D, Saxena S P, Murthy N S, Makwana U K.
Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients.
Hepatology.
1992;
16
1343-1349
-
19
Pache I, Bilodeau M.
Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease.
Aliment Pharmacol Ther.
2005;
21
525-529
-
20
Gines P, Cardenas A, Arroyo V, Rodes J.
Management of cirrhosis and ascites.
N Engl J Med.
2004;
350
1646-1654
-
21
Rimola A, Garcia-Tsao G, Navasa M. et al .
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club.
J Hepatol.
2000;
32
142-153
-
22
Sort P, Navasa M, Arroyo V. et al .
Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.
N Engl J Med.
1999;
341
403-409
M. Peck-Radosavljevic, M. D.
Abteilung für Gastroenterologie und Hepatologie, Klinik Innere Medizin IV
Medizinische Universität Wien · Währinger Gürtel 18 - 20 · A-1090 Wien
Phone: +43-1-40400-6589 ·
Fax: +43-1-40400-4735
Email: Markus.peck@meduniwien.ac.at
